Laquinimod

A board to discuss future MS therapies in early stage (Phase I or II) trials.
Post Reply
User avatar
bromley
Family Elder
Posts: 1898
Joined: Fri Sep 10, 2004 2:00 pm

Laquinimod

Post by bromley »

User avatar
gwa
Family Elder
Posts: 848
Joined: Thu Dec 01, 2005 3:00 pm

Post by gwa »

The main thrust of the med is to reduce lesion loan. Lesion load has been shown to have no bearing on progression of the disease or symptoms of the disease, so I am not sure what will be gained with this med.

gwa
User avatar
daverestonvirginia
Family Elder
Posts: 196
Joined: Mon Apr 09, 2007 2:00 pm
Location: Reston, Virginia
Contact:

Post by daverestonvirginia »

"Lesion load has been shown to have no bearing on progression of the disease or symptoms of the disease"

Is this really the case? I do not understand how having less lesions would not be a very good thing? Are not lessions the disease at work? I understand how lesions and symptoms might not be directly related, but I would think many lesions would not be good.
User avatar
lyndacarol
Family Elder
Posts: 3394
Joined: Thu Dec 22, 2005 3:00 pm
Contact:

Lesion load comment

Post by lyndacarol »

Dave, GWA is spot on about the lesion load! In fact, I begin to question the neurological connection at the onset of this disease at all. My first MRIs, EMG testing, and Evoked Potentials were all normal when my MS symptoms first began; it was months later that the MRI showed anything.

We must always remember the "individuality" aspect--my MS may not be like anyone else's.
Post Reply

Return to “Drug Pipeline”